Acute liver failure has a limited number of of causes. It is either toxins, ischaemia, sepsis, or viruses. And of the toxins, it is very often paracetamol. Weirder differentials may be presented in a question which does not specify how many differentials to provide; but if one is limited to (say) six, one should not bring up Amanita phalloides at the top.
The college love acute liver disease. It is typically presented as a "what caused this horrific LFT picture and this coma in a schizophrenic pregnant drug-using immunology patient". The following questions have been asked:
The various types of acute hepatic failure are divided into chronological niches:
These people collapse suddenly, and (aetiology permitting) they also bounce back rather rapidly. Typically this sort of hepatic failure presents with severe encephalopathy coagulopathy, and raised intracranial pressure. The LFTs tend to be ridiculously deranged.
The major causes in the developed world are paracetamol and hepatitis A or B.
These people collapse gradually over about a week.
The typical causes include hepatitis viruses and idiosyncratic drug reactions
This form of hepatic dyfunction creeps up on you gradually, and carries with it the poorest chance of meaningful recovery. This includes the frustrating "seronegative hepatitis" group, who have no positive tests but who behave like a viral hepatitis. The LFTs in this group are usually the least impressive.
In order to render this massive list more memorable, I have first attempted to pidgeonhole the aetiologies into the familiar VINDICATE matrix of differentials.
Idiopathic: idiosyncratic drug reactions:
Perhaps some basic LFTs will be in order. What these may mean is discussed in the chapter on interpretation of deranged LFTs
In addition, one may wish to order something more specific:
FBC for the eosinophil count (sometimes elevated in autoimmune hepatitis, and will likely be elevated in hepatitis due to some sort of idiosyncratic drug allergy)
LDH which is usually elevated in malignancy
CK and urinary myoglobin which will be elevated in hyperthermic injuries
Hepatitis A investigations: Anti-HAV, Hep A IGM
Hepatitis B investigations: Hep B core antibodies, surfance antigen, and Hep B DNA
Of the hepatitis viruses, A and C dont tend to cause acute liver failure.
It is mainly Hep B. One achieves the diagnosis of acute Hep B hepatitis by finding an IgM antibody to the Hep B core antigen. The surface antibody has long gone by the time the bloated yellow patient presents to hospital.
Uric acid which is elevated in fatty liver of pregnancy
Coags for DIC which forms part of HELLP syndrome
Urinary copper which is elevated in Wilson's disease
Ceruloplasmin which is abnormally low in Wilson's disease
EBV serology - in the immunocompromised host
CMV serology - in the immunocompromised host
HSV serology - in the immunocompromised host
Varicella serology - in the immunocompromised host
Dengue fever serology
Yellow fever serology
Anti-SSM: smooth muscle antibodies, which are positive in autimmune hepatitis.
To rule out right heart failure, a TTE should be performed.
This tends to become very important whe one is considered for transplantation.
They wont let you kill your nice new liver with your faulty old right ventricle.
A Doppler will assess the flows in the hepatic vessels, and rule out the vascular causes of acute failure. Additionally, one may be able to see hematomae and liver rupture in pregnancy, and one may be able to comment on the stone content of the gallbladder and the diameter of the common bile duct.
Metastatic deposits will be seen on CT. It will provide a lot of additional information regarding the abdominal organs, eg. wheter massive splenomegaly is present, whether the abdomen is full of lymph nodes, and whether there is liver rupture.
In acute hepatic necrosis, you very rarely get any useful information from this (as it will always come back as "acute necrosis" rather than anything diagnostic). One might be lucky enough to catch some tumour cells or something staining positive on immunofluorescence (eg. in autoimmune hepatitis). Generally speaking, CT-guided or transjugular biopsy are the safest methods.
Chapter 44 (pp. 501) Liver failure by Christopher Willars and Julia Wendon
Daly, Frank FS, et al. "Guidelines for the management of paracetamol poisoning in Australia and New Zealand-explanation and elaboration." Medical journal of Australia 188.5 (2008): 296.
Bailey, Benoit, René Blais, and Anne Letarte. "Status epilepticus after a massive intravenous N-acetylcysteine overdose leading to intracranial hypertension and death." Annals of emergency medicine 44.4 (2004): 401-406.
Parsons-Smith, B. G., et al. "The electroencephalograph in liver disease." The Lancet 270.7001 (1957): 867-871.
Ramos, Juan Francisco Rivera, and Celina Rodríguez Leal. "Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy." Ann Hepatol 10 (2011): S36-S39.
Walsh, Timothy S., et al. "Energy expenditure in acetaminophen-induced fulminant hepatic failure." Critical care medicine 28.3 (2000): 649-654.
Ichai, Philippe, et al. "Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis." Liver transplantation 13.7 (2007): 996-1003.
O’Grady, John G., et al. "Early indicators of prognosis in fulminant hepatic failure." Gastroenterology 97.2 (1989): 439-445.
Dhiman, Radha K., et al. "Early indicators of prognosis in fulminant hepatic failure: An assessment of the Model for End‐Stage Liver Disease (MELD) and King's College Hospital Criteria." Liver transplantation 13.6 (2007): 814-821.
Yantorno, Silvina E., et al. "MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure." Liver transplantation13.6 (2007): 822-828.
Wiesner, Russell, et al. "Model for end-stage liver disease (MELD) and allocation of donor livers." Gastroenterology 124.1 (2003): 91-96.
Gleisner, Ana L., et al. "Survival benefit of liver transplantation and the effect of underlying liver disease." Surgery 147.3 (2010): 392-404.
Ding, G. K. A., and N. A. Buckley. "Evidence and consequences of spectrum bias in studies of criteria for liver transplant in paracetamol hepatotoxicity." QJM101.9 (2008): 723-729.
Lee, William M., R. Todd Stravitz, and Anne M. Larson. "Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011." Hepatology 55.3 (2012): 965-967.
McPhail, Mark JW, Julia A. Wendon, and William Bernal. "Meta-analysis of performance of Kings’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure." Journal of hepatology 53.3 (2010): 492-499.